WallStreetZenWallStreetZen

NASDAQ: TCRX
Tscan Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tscan Therapeutics revenue was $2.82M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $665.0k, down 36.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TCRX annual revenue was $2.8M, with -86.6% growth year-over-year.

TCRX past revenue growth

How has TCRX's revenue growth performed historically?

Company
-86.62%
Industry
497.69%
Market
20.68%
TCRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TCRX revenue history

Current Revenue
$2.8M
Current Earnings
-$127.5M
Current Profit Margin
-4,527.7%

Be the first to know when TCRX announces revenue.

TCRX Revenue History By Year

TCRX Yearly RevenueTCRX RevenueTCRX ChangeTCRX Revenue Growth
2024-12-31$2.82M-$18.23M-86.62%
2023-12-31$21.05M$7.51M+55.52%
2022-12-31$13.54M$3.39M+33.47%
2021-12-31$10.14M$9.06M+834.65%
2020-12-31$1.09MN/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Tscan Therapeutics Revenue FAQ

What was TCRX's revenue last quarter?

Tscan Therapeutics (NASDAQ: TCRX) reported Q4 2024 revenue of $665.00 thousand up 90.78% year over year. In the same quarter last year, Tscan Therapeutics's revenue was $7.21 million.

What was Tscan Therapeutics's revenue in 2024?

Tscan Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $2.82 million, a 86.62% decrease year over year.

How much does Tscan Therapeutics make in a day?

Based on Tscan Therapeutics annual revenue for the past five years, TCRX makes an average of $26,644.38 per day.

What was Tscan Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Tscan Therapeutics's revenue has grown -86.62% year over year. This is 584.32 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Tscan Therapeutics's revenue in the past year totaled $2.82 million.

How much does Tscan Therapeutics make in a year?

Tscan Therapeutics's revenue by year for the past five years is:
  • Tscan Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $2.82 million, a 86.62% decrease year over year.
  • Tscan Therapeutics's annual revenue for Dec 31, 2023 was $21.05 million, a 55.52% increase from 2022.
  • Tscan Therapeutics's annual revenue for 2022 was $13.54 million, a 33.47% increase from 2021.
  • Tscan Therapeutics's annual revenue for 2021 was $10.14 million, a 834.65% increase from 2020.
  • Tscan Therapeutics's annual revenue for 2020 was $1.09 million, a Infinity% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.